Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
Disease mechanisms in MS: RNA profiling uncovers two distinct subsets of patients with multiple sclerosis.
[Review on domestic published papers regarding the acute disseminated encephalomyelitis and its relations with rabies vaccination].
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Long-term benefits of induction therapy in NMO: a case report.
Microglia: The constant gardeners.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.
Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
From genes to characteristics of multiple sclerosis.
[Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.]
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Fluctuations of MS births and UV-light exposure.

Pages